Xcout Intel
Retension Pharmaceuticals, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Retension Pharmaceuticals, Inc. — ranked by similarity to what Retension Pharmaceuticals, Inc. actually does, not by market-cap band.
Subscribe to see Retension Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Falls Church, Virginia, focused on optimizing blood pressure and cardiovascular health.
Retension Pharmaceuticals, Inc. at a glance
Retension Pharmaceuticals, Inc. is a company headquartered in United States. Its most recent funding round, Series A, raised $15M in August 2025. Xcout tracks 6 named people at Retension Pharmaceuticals, Inc., including Eric Keller (President).
Retension Pharmaceuticals, Inc. leadership
- Eric KellerPresident
- Dr. Bill SasielaChief Medical Officer
- Dr. Paul SweetnamChief Scientific Officer and Co-Founder
- Eric KellerExecutive Officer
- Donald OldsDirector
- Michael BerendtDirector
Retension Pharmaceuticals, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $15M | 1 named | |
| SEC Form D filing | $12.3M | — | |
| Series A | $10.4M | 1 named | |
| SEC Form D filing | $10.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Retension Pharmaceuticals, Inc. competitors
Ranked by semantic similarity — how close each company is to Retension Pharmaceuticals, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Therapeutics
Cardurion Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Burlington, Massachusetts, focused on discovering and developing novel therapeutics for cardiovascular diseases.
Close match by what they do
Response Pharmaceuticals, Inc. is a clinical-stage company based in Falls Church, Virginia, focused on weight management and metabolic health. The company develops pharmaceutical candidates such as RDX-002.
Close match by what they do
Proteon Therapeutics, Inc. is a biopharmaceutical company headquartered in Waltham, Massachusetts, dedicated to developing pharmaceuticals to address the medical needs of patients suffering from renal and vascular diseases.
Biotechnology
Imbria Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel cardiovascular therapies.
Biotech
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company that engages in the development of products to address pulmonary hypertension related to interstitial lung disease.
Close match by what they do
Armetheon, Inc. is a cardiovascular-focused, late-clinical stage specialty pharmaceutical company headquartered in Santa Clara, California, that develops and commercializes innovative medicines.
Biotechnology
OcuCure Therapeutics, Inc. is an ophthalmic pharmaceutical company located in Virginia that focuses on developing new proprietary drugs at the intersection of medical research and healthcare solutions.
Biotechnology
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania, with additional operations in San Diego, California. The company focuses on the discovery and development of novel biopharmaceuticals for cardiovascular and other severe diseases.
Close match by what they do
Renovion, Inc. is a clinical-stage biopharmaceutical company headquartered in Chapel Hill, North Carolina, focused on developing novel therapeutics for respiratory diseases and lung transplant patients.
Close match by what they do
Saghmos Therapeutics, Inc. is a privately held biopharmaceutical company based in Greenwich, Connecticut, focused on discovering and developing treatments for cardiometabolic and cardiorenal conditions.
Close match by what they do
ReEngage Therapeutics, Inc. is a biopharmaceutical company headquartered in Houston, Texas, focused on advancing clinical research and therapeutic treatments.
Close match by what they do
VasoCardea, Inc. is a biotechnology company located in Portland, Oregon, holding exclusive rights to develop novel therapeutic drug candidates and receptor antagonists.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Retension Pharmaceuticals, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Retension Pharmaceuticals, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →